Unicycive Therapeutics, Inc. (UNCY) stock
UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.57−0.13 (-3.51%)
Close on Nov 18, 2026Market cap $99.44MP/E –Yield –
Unicycive Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Unicycive Therapeutics's price to book ratio was 2.0× on Nov 11, 2026, against 3.6× a year earlier. Over the last 3 years it ranged from 0.8× to 10.0×, with a median of 3.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.0× | −1.2 |
| 2025 | Dec 31, 2025 | 3.2× | −6.4 |
| 2024 | Jan 31, 2024 | 9.6× | +0.8 |
| 2023 | Dec 29, 2023 | 8.8× | +7.0 |
| 2022 | Dec 30, 2022 | 1.8× | +0.1 |
| 2021 | Dec 31, 2021 | 1.6× | – |
See a number that looks wrong?